Header cover image

Pakistani (KSE) Healthcare Sector Analysis

UpdatedJun 06, 2023
DataAggregated Company Financials
Companies14
  • 7D0.3%
  • 3M-6.0%
  • 1Y-33.6%
  • YTD-14.9%

Over the last 7 days, the Healthcare industry has dropped 1.4%, driven by GlaxoSmithKline Pakistan declining 2.2%. Overall the industry is down 35% in 12 months. Looking forward, earnings are forecast to grow by 74% annually.

Sector Valuation and Performance

Has the Pakistani Healthcare Sector valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 06 Jun 2023PK₨148.5bPK₨230.4bPK₨11.0b12x13.5x0.6x
Thu, 04 May 2023PK₨155.1bPK₨217.8bPK₨14.9b8.8x10.4x0.7x
Sat, 01 Apr 2023PK₨157.6bPK₨214.7bPK₨16.5b9x9.5x0.7x
Mon, 27 Feb 2023PK₨156.3bPK₨211.8bPK₨16.8b8.6x9.3x0.7x
Wed, 25 Jan 2023PK₨153.7bPK₨211.8bPK₨16.8b8.7x9.1x0.7x
Fri, 23 Dec 2022PK₨175.7bPK₨210.9bPK₨16.9b9.2x10.4x0.8x
Sun, 20 Nov 2022PK₨207.0bPK₨210.0bPK₨16.6b11.1x12.5x1x
Tue, 18 Oct 2022PK₨217.3bPK₨202.0bPK₨18.9b11.4x11.5x1.1x
Thu, 15 Sep 2022PK₨222.9bPK₨193.0bPK₨20.3b10.4x11x1.2x
Sat, 13 Aug 2022PK₨233.5bPK₨189.9bPK₨23.3b9.9x10x1.2x
Mon, 11 Jul 2022PK₨237.5bPK₨188.5bPK₨23.1b10.2x10.3x1.3x
Wed, 08 Jun 2022PK₨226.0bPK₨185.8bPK₨23.1b9.5x9.8x1.2x
Fri, 06 May 2022PK₨249.4bPK₨185.3bPK₨23.1b10.1x10.8x1.3x
Sun, 03 Apr 2022PK₨256.8bPK₨181.2bPK₨21.4b11.2x12x1.4x
Tue, 01 Mar 2022PK₨255.7bPK₨180.0bPK₨21.5b11.8x11.9x1.4x
Thu, 27 Jan 2022PK₨262.9bPK₨180.0bPK₨21.5b11.9x12.2x1.5x
Sat, 25 Dec 2021PK₨263.8bPK₨180.0bPK₨21.5b12.4x12.3x1.5x
Mon, 22 Nov 2021PK₨287.9bPK₨179.9bPK₨21.5b13.3x13.4x1.6x
Wed, 20 Oct 2021PK₨292.0bPK₨173.6bPK₨20.7b14.6x14.1x1.7x
Fri, 17 Sep 2021PK₨303.4bPK₨170.6bPK₨19.1b16.6x15.8x1.8x
Sun, 15 Aug 2021PK₨312.3bPK₨170.6bPK₨19.1b19.5x16.3x1.8x
Thu, 10 Jun 2021PK₨291.0bPK₨157.5bPK₨17.3b17x16.8x1.8x
Wed, 03 Mar 2021PK₨305.6bPK₨151.9bPK₨15.5b16.7x19.7x2x
Sat, 05 Dec 2020PK₨280.5bPK₨148.4bPK₨13.6b21.2x20.7x1.9x
Tue, 08 Sep 2020PK₨296.8bPK₨142.0bPK₨12.3b25.8x24.1x2.1x
Price to Earnings Ratio

20.9x


Total Market Cap: PK₨256.7bTotal Earnings: PK₨12.3bTotal Revenue: PK₨141.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Pakistani Healthcare Sector Price to Earnings3Y Average 14.5x202120222023
Current Industry PE
  • Investors are relatively neutral on the Pakistani Healthcare industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 14.5x.
  • The 3-year average PS ratio of 1.5x is higher than the industry's current PS ratio of 0.64x.
Past Earnings Growth
  • The earnings for companies in the Healthcare industry have declined 3.7% per year over the last three years.
  • Meanwhile revenues for these companies have grown 18% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the Pakistani Healthcare sector?

PK Market0.96%
Healthcare0.28%
Life Sciences6.01%
Pharma0.073%
Medical Equipment0%
Healthtech0%
Biotech0%
Healthcare Services-0.27%
Industry PE
  • Investors are most optimistic about the Life Sciences industry even though it's trading below its 3-year average PE ratio of 70.4x.
    • It looks like they are confident that earnings will grow faster in the future than they have historically.
  • Investors are most pessimistic about the Healthcare Services industry, which is trading below its 3-year average of 39.9x.
Forecasted Growth
  • Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 74% over the next 5 years.
  • This is better than its past earnings decline of 66% per year.
  • In contrast, the Pharma industry is expected to see its earnings grow by 74% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ABOT Abbott Laboratories (Pakistan)PK₨398.001.9%
+PK₨720.5m
-38.8%PE29x
MACTER Macter InternationalPK₨104.907.3%
+PK₨328.9m
-16.6%n/a
SAPL sanofi-aventis PakistanPK₨756.002.2%
+PK₨154.3m
-13.1%PE43.7x
FEROZ Ferozsons LaboratoriesPK₨139.091.6%
+PK₨96.1m
-32.1%PE36.9x
CPHL Citi PharmaPK₨22.361.7%
+PK₨86.8m
-24.3%PE8.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

GLAXO

PK₨80.00

GlaxoSmithKline Pakistan

7D

-2.2%

1Y

-33.2%

MACTER

PK₨104.90

Macter International

7D

7.3%

1Y

-16.6%

SAPL

PK₨756.00

sanofi-aventis Pakistan

7D

2.2%

1Y

-13.1%

GGGL

PK₨5.88

Ghani Global Glass

7D

1.6%

1Y

-48.7%

IBLHL

PK₨31.89

IBL HealthCare

7D

0.7%

1Y

-15.0%

AGP

PK₨51.93

AGP

7D

-1.8%

1Y

-34.3%

OTSU

PK₨73.00

Otsuka Pakistan

7D

-0.03%

1Y

-67.4%

HINOON

PK₨414.98

Highnoon Laboratories

7D

-0.4%

1Y

-11.7%

SEARL

PK₨42.16

Searle

7D

-0.2%

1Y

-47.9%

SHFA

PK₨124.33

Shifa International Hospitals

7D

-0.5%

1Y

-30.9%

FEROZ

PK₨139.09

Ferozsons Laboratories

7D

1.6%

1Y

-32.1%

CPHL

PK₨22.36

Citi Pharma

7D

1.7%

1Y

-24.3%

META

PK₨6.64

MetaTech Health

7D

-4.7%

1Y

n/a

ABOT

PK₨398.00

Abbott Laboratories (Pakistan)

7D

1.9%

1Y

-38.8%